4//SEC Filing
WALLEN WILLIAM C 4
Accession 0001140361-10-004715
CIK 0000874716other
Filed
Feb 7, 7:00 PM ET
Accepted
Feb 8, 5:19 PM ET
Size
14.3 KB
Accession
0001140361-10-004715
Insider Transaction Report
Form 4
WALLEN WILLIAM C
Senior Vice President
Transactions
- Sale
Common Stock
2010-02-04$50.32/sh−10,000$503,224→ 18,668 total - Exercise/Conversion
Common Stock
2010-02-08$21.30/sh+13,530$288,189→ 32,198 total - Sale
Common Stock
2010-02-08$50.00/sh−13,530$676,500→ 18,668 total - Exercise/Conversion
Non-Qualified Stock Options (right to buy)
2010-02-04−10,000→ 13,530 totalExercise: $21.30Exp: 2013-09-08→ Common Stock (10,000 underlying) - Exercise/Conversion
Common Stock
2010-02-04$21.30/sh+10,000$213,000→ 28,668 total - Exercise/Conversion
Non-Qualified Stock Options (right to buy)
2010-02-08−13,530→ 0 totalExercise: $21.30Exp: 2013-09-08→ Common Stock (13,530 underlying)
Footnotes (3)
- [F1]The sale price reported above reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged between $50.20 and $50.41. The reporting person hereby undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.
- [F2]Includes 54 shares of common stock acquired pursuant to the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on September 30, 2009.
- [F3]Grant of options to buy shares of common stock becomes exercisable in five equal annual increments, beginning on the first anniversary date (9/8/2004) of the date of grant.
Documents
Issuer
IDEXX LABORATORIES INC /DE
CIK 0000874716
Entity typeother
Related Parties
1- filerCIK 0001263078
Filing Metadata
- Form type
- 4
- Filed
- Feb 7, 7:00 PM ET
- Accepted
- Feb 8, 5:19 PM ET
- Size
- 14.3 KB